Scandinavian Working Papers in Economics
HERO Online Working Paper Series,
University of Oslo, Health Economics Research Programme
No 2007:7: Economic consequences of near-patient test results - the case of tests for the Helicobacter Pylori bacterium in dyspepsia
Siri Fauli () and Geir Thue
Additional contact information
Siri Fauli: The Norwegian Medical Association, Postal: The Norwegian Medical Association & NOKLUS,, P.O.Box 1152 Sentrum, N-0107 Oslo, Norway
Geir Thue: Department of Public Health and Primary Health Care, University of Bergen, Postal: and The Norwegian Quality Improvement of Laboratory Services in Primary Care
Abstract: Abstract Diagnostic tests and in particular laboratory tests are often important in diagnostic work-up and monitoring of patients. Therefore the economic consequences of medical actions based on test results may amount to a substantial proportion of health service costs. Thus, it is of public interest to study the consequences and costs of using laboratory tests. We develop a model for economic evaluation related to the diagnostic accuracy (sensitivity and specificity) of near patient tests. Blood sample based tests to detect the bacterium Helicobacter Pylori (HP) are useful in diagnosing peptic ulcer and suitable to illustrate the model. First, general practitioners’ initial management plans for a dyspeptic patient are elucidated using a paper vignette survey. Based on survey results, and medical literature, a decision tree is constructed to visualize expected costs and outcomes resulting from using three different HP tests in the clinical situation described in the vignette. Tests included are two rapid tests for use in general practice, and one hospital laboratory test for comparison. The tests had different sensitivities and specificities. Then a costeffectiveness analysis is undertaken from a societal perspective. Finally we use sensitivity analyses to model the decision uncertainty. Estimating for a follow-up period of 120 days, the rapid test with lower sensitivity and specificity than the hospital HP test is cost-effective because the laboratory result is available immediately. Further, in general practice, the rapid test with the highest sensitivity is significantly cost effective compared to the test with the highest specificity when the willingness to pay for each dyspepsia-free day exceeds €42.6. When deciding whether a laboratory analysis should be analysed in the office laboratory or not, it is important to consider both the diagnostic accuracy of the tests and the waiting time for the alternative, i.e. a hospital laboratory result.
Keywords: cost-effectiveness; laboratory tests; general practice; probabilistic sensitivity; analysis
JEL-codes: I18
65 pages, June 3, 2009
Full text files
HERO2007_7.pdf
Questions (including download problems) about the papers in this series should be directed to Kristi Brinkmann Lenander ()
Report other problems with accessing this service to Sune Karlsson ().
RePEc:hhs:oslohe:2007_007This page generated on 2024-09-13 22:16:49.